by Clinical Neuropsychologist Online | Monday, July 29, 2024 | Dementia
Dementia, Volume 23, Issue 8, Page 1416-1418, November 2024. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Lily Haopu Ren | July 29, 2024 SAGE...
by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION This study investigates primary lateral sclerosis (PLS) as a rare manifestation of the presenilin 1 (PSEN1) NM_000021 c.851C > T p.Pro284Leu variant in three siblings of a Colombian family, outlining its clinical and neuropathological features...
by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION Subjective cognitive decline (SCD) in amyloid-positive (Aβ+) individuals was proposed as a clinical indicator of Stage 2 in the Alzheimer’s disease (AD) continuum, but this requires further validation across cultures, measures, and...
by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION Older adults with multimorbidity are at high risk of cognitive impairment development. There is a lack of research on the associations between different multimorbidity measures and cognitive function among older Chinese adults living in the...
by Clinical Neuropsychologist Online | Sunday, July 28, 2024 | Dementia
Abstract INTRODUCTION Amid recent approvals, early Alzheimer’s disease (AD) remains an active area of treatment development. METHODS We performed a conjoint experiment to compare preferences among 26 patients with mild cognitive impairment for four trial...
